Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

At Neurogene, our mission is to turn devastating neurological diseases into treatable conditions, to improve the lives of patients and families impacted by these rare diseases. Our core values are the foundation of everything we do.

News

News YahooFinance 6 months ago
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, March 03, 2026--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Comp
Read more
Report
Blog 11 months ago
Page Heading (H2)
Welcome to WordPress Heading (H2) This is your first post. Edit or delete it, then start writing! Sample bullet for style testing Sample bullet for style testing Sample bullet for style testing Here's a sentence to test line spacing and font style. Sample
Read more
Report
What's next for brain-directed gene therapy after death in Neurogene trial
The incident highlights that viral vectors can trigger deadly immune responses even when delivered directly to the nervous system.
Read more
Report
News pharmaphorum 2 years ago
Neurogene drops high-dose arm in Rett study after death
The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died.
Read more
Report
Pro access
Upgrade to see all 12 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

People

Rachel McMinn
Executive Officer, Director
Christine Cvijic
Executive Officer
Cory Freedland
Director
Stephen Biggar
Director
Robert Baffi
Director
Caroline Stout
Director
Srdjan Stankovic
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
New York United States
HQ
Our Corporate Headquarters
535 W 24th Street, 5th Floor, New York, NY 10011
company site
Houston United States
Plant / site
Our Manufacturing Facility
Houston, TX 77025
company site

Financials

Total raised
$106.5M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2020 $69M Details
Venture - Series Unknown 2019 $37.5M Details